Sarcoidosis: an update on current pharmacotherapy options and future directions.

about

A rare presentation of pulmonary sarcoidosis as a solitary lung mass: a case report.

P2860

Q52591398-FFF83CFF-3ECA-42E6-9CD0-E1A258E71982

P2860

Sarcoidosis: an update on current pharmacotherapy options and future directions.

Item

http://www.wikidata.org/entity/Q38798146

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sarcoidosis: an update on current pharmacotherapy options and future directions.

@en

type

Item

label

Sarcoidosis: an update on current pharmacotherapy options and future directions.

@en

prefLabel

Sarcoidosis: an update on current pharmacotherapy options and future directions.

@en

P1476

Sarcoidosis: an update on current pharmacotherapy options and future directions.

@en

P2093

Lucio Pallarés

http://www.w3.org/2001/XMLSchema#string

Pilar Brito-Zerón

http://www.w3.org/2001/XMLSchema#string

Robert P Baughman

http://www.w3.org/2001/XMLSchema#string

Roberto Pérez-Alvarez

http://www.w3.org/2001/XMLSchema#string

SarcoGEAS-SEMI Study Group

http://www.w3.org/2001/XMLSchema#string

Soledad Retamozo

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcoidosis diagnosed after September 11, 2001, among adults exposed to the World Trade Center disaster

Corticosteroids for pulmonary sarcoidosis

Current and emerging pharmacological treatments for sarcoidosis: a review

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases.

The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital.

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial.

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.

Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review.

P304

2431-2448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1258061

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Ramos-casals

P577

2016-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27817209

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Sarcoidosis: an update on current pharmacotherapy options and future directions.

about

P2860

P2860

Sarcoidosis: an update on current pharmacotherapy options and future directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921